{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:29Z","timestamp":1789524149117,"version":"build-2803163510"},"reference-count":34,"publisher":"Cold Spring Harbor Laboratory","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Mol Case Stud"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Bloom syndrome (BS) is a rare, autosomal recessive genetic disorder characterized by short stature, a skin rash associated with sun exposure, and an elevated likelihood of developing cancers of essentially all types, beginning at an early age. Cancer is the leading cause of death for persons with BS, and its early onset results in a reported median lifespan of &lt;30 years. With fewer than 300 documented cases since BS was first described in 1954, its rarity has challenged progress in advancing both the care of and the cure for persons with BS. Presently, there are no known clinically actionable targets specific to persons with this cancer predisposition syndrome, despite the fact that standard cancer treatments are often contraindicated or must be substantially modified for persons with BS. Herein, Zachary Rogers recounts his experience as a cancer patient with BS contemplating a substantially customized chemotherapy regimen that highlights the need for development of individualized treatments in the BS community. We also outline a patient-centered research and community action road map with the goal of improving and prolonging the lives of persons with Bloom syndrome, including the facilitation of precision medicine development specific to this condition.<\/jats:p>","DOI":"10.1101\/mcs.a002816","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T13:45:21Z","timestamp":1522676721000},"page":"a002816","source":"Crossref","is-referenced-by-count":21,"title":["Bloom syndrome: research and data priorities for the development of precision medicine as identified by some affected families"],"prefix":"10.1101","volume":"4","author":[{"given":"Mary Beth","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"van den Hurk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talon","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zaslaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"2021112406070426000_4.2.a002816.1","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2015.1027853"},{"key":"2021112406070426000_4.2.a002816.2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01402-06"},{"key":"2021112406070426000_4.2.a002816.3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620982114"},{"key":"2021112406070426000_4.2.a002816.4","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.1007\/s11033-014-3624-5","article-title":"A novel frameshift mutation in BLM gene associated with high sister chromatid exchanges (SCE) in heterozygous family members","volume":"41","year":"2014","journal-title":"Mol Biol Rep"},{"key":"2021112406070426000_4.2.a002816.5","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1954.02050100756008"},{"key":"2021112406070426000_4.2.a002816.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.09.004"},{"key":"2021112406070426000_4.2.a002816.7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.11.4508"},{"key":"2021112406070426000_4.2.a002816.8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060713-035428"},{"key":"2021112406070426000_4.2.a002816.9","doi-asserted-by":"publisher","DOI":"10.1159\/000452082"},{"key":"2021112406070426000_4.2.a002816.10","doi-asserted-by":"publisher","DOI":"10.1159\/000093826"},{"key":"2021112406070426000_4.2.a002816.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2008.09.005"},{"key":"2021112406070426000_4.2.a002816.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1618389114"},{"key":"2021112406070426000_4.2.a002816.13","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20501"},{"key":"2021112406070426000_4.2.a002816.14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaad.2016.03.045","article-title":"Understanding photodermatoses associated with defective DNA repair: syndromes with cancer predisposition","volume":"75","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2021112406070426000_4.2.a002816.15","first-page":"30","article-title":"Microsatellite instability testing and its role in the management of colorectal cancer","volume":"16","year":"2016","journal-title":"Curr Treat Options Oncol"},{"key":"2021112406070426000_4.2.a002816.16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700031"},{"key":"2021112406070426000_4.2.a002816.17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2199-13-33","article-title":"Escherichia coli RecG functionally suppresses human Bloom syndrome phenotypes","volume":"13","year":"2012","journal-title":"BMC Mol Biol"},{"key":"2021112406070426000_4.2.a002816.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312088110"},{"key":"2021112406070426000_4.2.a002816.19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-5037-5"},{"key":"2021112406070426000_4.2.a002816.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.07.007"},{"key":"2021112406070426000_4.2.a002816.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2015.21"},{"key":"2021112406070426000_4.2.a002816.22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1011106202939","article-title":"Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom's syndrome: a case report and review of the literature","volume":"12","year":"2001","journal-title":"Ann Oncol"},{"key":"2021112406070426000_4.2.a002816.23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00066-012-0274-1","article-title":"Proton beam therapy for malignancy in Bloom syndrome","volume":"189","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"2021112406070426000_4.2.a002816.24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg.2017.47","article-title":"Synthetic lethality and cancer","volume":"18","year":"2017","journal-title":"Nat Rev Genet"},{"key":"2021112406070426000_4.2.a002816.25","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2014.111"},{"key":"2021112406070426000_4.2.a002816.26","first-page":"151","article-title":"Zebrafish as a model system to study DNA damage and repair","volume":"743\u2013744","year":"2013","journal-title":"Mutat Res"},{"key":"2021112406070426000_4.2.a002816.27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010814-124454"},{"key":"2021112406070426000_4.2.a002816.28","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1056\/NEJMra1612575","article-title":"Academic, foundation, and industry collaboration in finding new therapies","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"2021112406070426000_4.2.a002816.29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2491"},{"key":"2021112406070426000_4.2.a002816.30","unstructured":"Sanz MM , German J , Cunniff C . 2006. Bloom's Syndrome Mar 22 [Updated 2016 Apr 7]. In GeneReviews\u00ae [Internet] (ed. Pagon RA , Adam MP , Ardinger HH , ). University of Washington, Seattle, Seattle, WA; 1993\u20132017."},{"key":"2021112406070426000_4.2.a002816.31","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30249-2"},{"key":"2021112406070426000_4.2.a002816.32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0465"},{"key":"2021112406070426000_4.2.a002816.33","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.10.3527-3535.2003"},{"key":"2021112406070426000_4.2.a002816.34","first-page":"78","article-title":"Engineered swine models of cancer","volume":"7","year":"2016","journal-title":"Front Genet"}],"container-title":["Molecular Case Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/mcs.a002816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T14:11:37Z","timestamp":1637763097000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularcasestudies.cshlp.org\/lookup\/doi\/10.1101\/mcs.a002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,4,2]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1101\/mcs.a002816"],"URL":"https:\/\/doi.org\/10.1101\/mcs.a002816","relation":{},"ISSN":["2373-2865","2373-2873"],"issn-type":[{"value":"2373-2865","type":"print"},{"value":"2373-2873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}